Literature DB >> 26704449

Pluripotent stem cells induced from mouse neural stem cells and small intestinal epithelial cells by small molecule compounds.

Junqing Ye1,2, Jian Ge1,2, Xu Zhang1,2, Lin Cheng1,2, Zhengyuan Zhang1,2, Shan He1,2, Yuping Wang3, Hua Lin3, Weifeng Yang4, Junfang Liu1,2, Yang Zhao1,2,5, Hongkui Deng1,2.   

Abstract

Recently, we reported a chemical approach to generate pluripotent stem cells from mouse fibroblasts. However, whether chemically induced pluripotent stem cells (CiPSCs) can be derived from other cell types remains to be demonstrated. Here, using lineage tracing, we first verify the generation of CiPSCs from fibroblasts. Next, we demonstrate that neural stem cells (NSCs) from the ectoderm and small intestinal epithelial cells (IECs) from the endoderm can be chemically reprogrammed into pluripotent stem cells. CiPSCs derived from NSCs and IECs resemble mouse embryonic stem cells in proliferation rate, global gene expression profile, epigenetic status, self-renewal and differentiation capacity, and germline transmission competency. Interestingly, the pluripotency gene Sall4 is expressed at the initial stage in the chemical reprogramming process from different cell types, and the same core small molecules are required for the reprogramming, suggesting conservation in the molecular mechanism underlying chemical reprogramming from these diverse cell types. Our analysis also shows that the use of these small molecules should be fine-tuned to meet the requirement of reprogramming from different cell types. Together, these findings demonstrate that full chemical reprogramming approach can be applied in cells of different tissue origins and suggest that chemical reprogramming is a promising strategy with the potential to be extended to more initial types.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26704449      PMCID: PMC4816130          DOI: 10.1038/cr.2015.142

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  42 in total

1.  A XEN-like State Bridges Somatic Cells to Pluripotency during Chemical Reprogramming.

Authors:  Yang Zhao; Ting Zhao; Jingyang Guan; Xu Zhang; Yao Fu; Junqing Ye; Jialiang Zhu; Gaofan Meng; Jian Ge; Susu Yang; Lin Cheng; Yaqin Du; Chaoran Zhao; Ting Wang; Linlin Su; Weifeng Yang; Hongkui Deng
Journal:  Cell       Date:  2015-12-10       Impact factor: 41.582

2.  Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds.

Authors:  Pingping Hou; Yanqin Li; Xu Zhang; Chun Liu; Jingyang Guan; Honggang Li; Ting Zhao; Junqing Ye; Weifeng Yang; Kang Liu; Jian Ge; Jun Xu; Qiang Zhang; Yang Zhao; Hongkui Deng
Journal:  Science       Date:  2013-07-18       Impact factor: 47.728

Review 3.  Understanding fibroblast heterogeneity in the skin.

Authors:  Ryan R Driskell; Fiona M Watt
Journal:  Trends Cell Biol       Date:  2014-11-07       Impact factor: 20.808

4.  GATA family members as inducers for cellular reprogramming to pluripotency.

Authors:  Jian Shu; Ke Zhang; Minjie Zhang; Anzhi Yao; Sida Shao; Fengxia Du; Caiyun Yang; Wenhan Chen; Chen Wu; Weifeng Yang; Yingli Sun; Hongkui Deng
Journal:  Cell Res       Date:  2015-01-16       Impact factor: 25.617

5.  Nonstochastic reprogramming from a privileged somatic cell state.

Authors:  Shangqin Guo; Xiaoyuan Zi; Vincent P Schulz; Jijun Cheng; Mei Zhong; Sebastian H J Koochaki; Cynthia M Megyola; Xinghua Pan; Kartoosh Heydari; Sherman M Weissman; Patrick G Gallagher; Diane S Krause; Rong Fan; Jun Lu
Journal:  Cell       Date:  2014-01-30       Impact factor: 41.582

6.  Single-cell expression analyses during cellular reprogramming reveal an early stochastic and a late hierarchic phase.

Authors:  Yosef Buganim; Dina A Faddah; Albert W Cheng; Elena Itskovich; Styliani Markoulaki; Kibibi Ganz; Sandy L Klemm; Alexander van Oudenaarden; Rudolf Jaenisch
Journal:  Cell       Date:  2012-09-14       Impact factor: 41.582

7.  Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man.

Authors:  R Eissele; R Göke; S Willemer; H P Harthus; H Vermeer; R Arnold; B Göke
Journal:  Eur J Clin Invest       Date:  1992-04       Impact factor: 4.686

8.  Isolation of multipotent neural stem or progenitor cells from both the dentate gyrus and subventricular zone of a single adult mouse.

Authors:  Weixiang Guo; Natalie E Patzlaff; Emily M Jobe; Xinyu Zhao
Journal:  Nat Protoc       Date:  2012-10-18       Impact factor: 13.491

9.  Cis elements of the villin gene control expression in restricted domains of the vertical (crypt) and horizontal (duodenum, cecum) axes of the intestine.

Authors:  Blair B Madison; Laura Dunbar; Xiaotan T Qiao; Katherine Braunstein; Evan Braunstein; Deborah L Gumucio
Journal:  J Biol Chem       Date:  2002-06-13       Impact factor: 5.157

10.  Combinatorial modulation of signaling pathways reveals cell-type-specific requirements for highly efficient and synchronous iPSC reprogramming.

Authors:  Simon E Vidal; Bhishma Amlani; Taotao Chen; Aristotelis Tsirigos; Matthias Stadtfeld
Journal:  Stem Cell Reports       Date:  2014-10-14       Impact factor: 7.765

View more
  26 in total

1.  The XEN of reprogramming.

Authors:  Ergin Beyret; Juan Carlos Izpisua Belmonte
Journal:  Cell Res       Date:  2016-01-22       Impact factor: 25.617

Review 2.  Small molecules for reprogramming and transdifferentiation.

Authors:  Hua Qin; Andong Zhao; Xiaobing Fu
Journal:  Cell Mol Life Sci       Date:  2017-07-11       Impact factor: 9.261

Review 3.  An Insight into DNA-free Reprogramming Approaches to Generate Integration-free Induced Pluripotent Stem Cells for Prospective Biomedical Applications.

Authors:  Manash P Borgohain; Krishna Kumar Haridhasapavalan; Chandrima Dey; Poulomi Adhikari; Rajkumar P Thummer
Journal:  Stem Cell Rev Rep       Date:  2019-04       Impact factor: 5.739

Review 4.  Chemical transdifferentiation: closer to regenerative medicine.

Authors:  Aining Xu; Lin Cheng
Journal:  Front Med       Date:  2016-05-03       Impact factor: 4.592

Review 5.  Looking to the future following 10 years of induced pluripotent stem cell technologies.

Authors:  Mo Li; Juan Carlos Izpisua Belmonte
Journal:  Nat Protoc       Date:  2016-08-04       Impact factor: 13.491

Review 6.  Pluripotent stem cells: induction and self-renewal.

Authors:  R Abu-Dawud; N Graffmann; S Ferber; W Wruck; J Adjaye
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-07-05       Impact factor: 6.237

Review 7.  Application of stem cell-derived retinal pigmented epithelium in retinal degenerative diseases: present and future.

Authors:  Mingyue Luo; Youxin Chen
Journal:  Int J Ophthalmol       Date:  2018-01-18       Impact factor: 1.779

Review 8.  Non-viral reprogramming and induced pluripotent stem cells for cardiovascular therapy.

Authors:  Arunima Panda; Narasimman Gurusamy; Sheeja Rajasingh; Hannah-Kaye Carter; Edwin L Thomas; Johnson Rajasingh
Journal:  Differentiation       Date:  2020-01-10       Impact factor: 3.880

Review 9.  Phenotypic technologies in stem cell biology.

Authors:  J Jeya Vandana; Lauretta A Lacko; Shuibing Chen
Journal:  Cell Chem Biol       Date:  2021-03-01       Impact factor: 8.116

Review 10.  A Concise Review on Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Personalized Regenerative Medicine.

Authors:  Pallavi Pushp; Diogo E S Nogueira; Carlos A V Rodrigues; Frederico C Ferreira; Joaquim M S Cabral; Mukesh Kumar Gupta
Journal:  Stem Cell Rev Rep       Date:  2020-10-23       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.